Subjects were followed for 24 (VISP), 40 (NORVIT), 60 (HOPE-2), 88 (WAFACS), 41 (VITATOPS), or 80 months (SEARCH)
Phase II human trials of thymosin beta-4 (TB-500's parent molecule) have been conducted examining tissue repair rates, though detailed results remain limited in peer-reviewed literature
These changes could perhaps improve postnatal growth in the piglets [52]
The Journal of physiology, 589(Pt 4), 963973
Some therapies, like NAD+, peptides, and certain injectables, do require a consultation and, in certain cases, lab work to make sure treatment is safe and appropriate
Many researchers study them in combination for additive regenerative effects